News Details

( As on 13/12/2025 13:41)

Biocon - Press Release

Biocon Limited has informed the Exchange regarding a press release dated December 13, 2025, titled ""Biocon Biologics Signs Settlement and License Agreement to Commercialize Biosimilar Aflibercept Worldwide"".